Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Modified-Release Drug Delivery Systems: Stimuli-Activated01:30

Modified-Release Drug Delivery Systems: Stimuli-Activated

Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quatsome nanovesicles as antibacterial platform: Mechanistic insights into their activity against planktonic and biofilm Staphylococcus aureus.

Colloids and surfaces. B, Biointerfaces·2026
Same author

Quatsomes as versatile fluorescent nanocarriers: stable Eosin Y loading and FRET with a membrane dye.

Nanoscale advances·2026
Same author

In vivo evaluation of the antitumor peptide CIGB-552: antitumor activity, pharmacokinetics and safety of the subcutaneously administered peptide.

Cancer chemotherapy and pharmacology·2026
Same author

Stable ultrabright nanoprobes for two-photon excitation microscopy based on octupolar merocyanine-loaded nanovesicles.

Journal of materials chemistry. B·2026
Same author

Intrinsically Chiral Excimers: Water-Compatible Trityl-Based Nanoparticles as Tailored Dual Emitters of Circularly Polarized Luminescence in the Vis or NIR Regions.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

Systemically inducing trained immunity overcomes solid tumors' immunosuppressive microenvironment.

Science advances·2026

Related Experiment Video

Updated: Jul 9, 2026

Fabricating Degradable Thermoresponsive Hydrogels on Multiple Length Scales via Reactive Extrusion, Microfluidics, Self-assembly, and Electrospinning
12:07

Fabricating Degradable Thermoresponsive Hydrogels on Multiple Length Scales via Reactive Extrusion, Microfluidics, Self-assembly, and Electrospinning

Published on: April 16, 2018

13.6K

DELOS Nanovesicles-Based Hydrogels: An Advanced Formulation for Topical Use.

Lídia Ballell-Hosa1,2,3, Elisabet González-Mira2,3, Hector Santana4

  • 1Nanomol Technologies S.L., 08193 Cerdanyola del Vallès, Spain.

Pharmaceutics
|January 21, 2022
PubMed
Summary

DELOS nanovesicles were successfully formulated into stable hydrogels for enhanced topical drug delivery. This advanced formulation maintains nanocarrier integrity and improves the bioactivity of encapsulated therapeutics like recombinant human Epidermal Growth Factor (rhEGF).

Keywords:
hydrogelnanovesiclesrheologytopical drug deliveryvesicle integrity

More Related Videos

Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications
09:39

Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications

Published on: February 7, 2021

8.2K
Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization
06:26

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization

Published on: January 24, 2025

1.3K

Related Experiment Videos

Last Updated: Jul 9, 2026

Fabricating Degradable Thermoresponsive Hydrogels on Multiple Length Scales via Reactive Extrusion, Microfluidics, Self-assembly, and Electrospinning
12:07

Fabricating Degradable Thermoresponsive Hydrogels on Multiple Length Scales via Reactive Extrusion, Microfluidics, Self-assembly, and Electrospinning

Published on: April 16, 2018

13.6K
Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications
09:39

Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications

Published on: February 7, 2021

8.2K
Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization
06:26

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization

Published on: January 24, 2025

1.3K

Area of Science:

  • Biomaterials Science
  • Drug Delivery Systems
  • Dermatology

Background:

  • Topical drug delivery offers localized treatment with improved patient compliance and reduced side effects.
  • Current topical treatments face challenges that innovative drug delivery systems aim to address.
  • DELOS nanovesicles have shown potential for topical complex wound treatment.

Purpose of the Study:

  • To develop DELOS nanovesicles with optimal skin tolerability for application on damaged skin.
  • To adapt DELOS nanovesicle dispersions into a suitable topical hydrogel formulation.
  • To confirm nanocarrier integrity post-gellification and evaluate the bioactivity of encapsulated rhEGF.

Main Methods:

  • Formulation of DELOS nanovesicles into hydrogels using Methocel™ K4M.
  • Characterization of hydrogel stability and rheological properties.
  • Confirmation of nanocarrier integrity via cryo-transmission electron microscopy and Förster resonance energy transfer analysis.
  • In vitro assessment of rhEGF bioactivity in gellified versus liquid nanovesicles.

Main Results:

  • DELOS nanovesicles were successfully incorporated into stable hydrogels with appropriate rheological properties.
  • Nanocarrier integrity was confirmed after hydrogel formation, a critical but rarely reported finding.
  • Recombinant human Epidermal Growth Factor (rhEGF) within the hydrogel formulation showed enhanced bioactivity compared to the liquid form.

Conclusions:

  • DELOS nanovesicles can be effectively formulated into hydrogels without compromising their integrity.
  • DELOS nanovesicles-based hydrogels represent an advanced topical drug delivery system.
  • This formulation enhances the bioactivity of encapsulated therapeutic proteins for topical applications.